company background image
BGLA logo

BioGaia DB:BGLA Stock Report

Last Price

€9.50

Market Cap

€970.2m

7D

1.5%

1Y

10.2%

Updated

23 Dec, 2024

Data

Company Financials +

BGLA Stock Overview

A healthcare company, provides probiotic products worldwide. More details

BGLA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance3/6
Financial Health6/6
Dividends4/6

My Notes

Capture your thoughts, links and company narrative

BioGaia AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for BioGaia
Historical stock prices
Current Share PriceSEK 9.50
52 Week HighSEK 11.63
52 Week LowSEK 8.36
Beta0.58
1 Month Change6.56%
3 Month Change-5.85%
1 Year Change10.21%
3 Year Change-2.36%
5 Year Change14.18%
Change since IPO991.11%

Recent News & Updates

Recent updates

Shareholder Returns

BGLADE BiotechsDE Market
7D1.5%-3.5%-2.0%
1Y10.2%-14.7%6.9%

Return vs Industry: BGLA exceeded the German Biotechs industry which returned -14.7% over the past year.

Return vs Market: BGLA exceeded the German Market which returned 6.9% over the past year.

Price Volatility

Is BGLA's price volatile compared to industry and market?
BGLA volatility
BGLA Average Weekly Movement3.9%
Biotechs Industry Average Movement6.8%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.3%
10% least volatile stocks in DE Market2.4%

Stable Share Price: BGLA has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: BGLA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1990222Theresa Agnewwww.biogaia.com

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula.

BioGaia AB (publ) Fundamentals Summary

How do BioGaia's earnings and revenue compare to its market cap?
BGLA fundamental statistics
Market cap€970.17m
Earnings (TTM)€29.31m
Revenue (TTM)€117.98m

33.1x

P/E Ratio

8.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BGLA income statement (TTM)
RevenueSEK 1.36b
Cost of RevenueSEK 358.07m
Gross ProfitSEK 997.60m
Other ExpensesSEK 660.78m
EarningsSEK 336.82m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 12, 2025

Earnings per share (EPS)3.33
Gross Margin73.59%
Net Profit Margin24.85%
Debt/Equity Ratio0%

How did BGLA perform over the long term?

See historical performance and comparison

Dividends

6.3%

Current Dividend Yield

57%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 02:41
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioGaia AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher UhdeABG Sundal Collier Sponsored
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Mattias HäggblomDanske Bank